Inventor · disambiguated record
Yoshiteru Ito
Also filed as: ITO YOSHITERU
21 granted patents·7 pending applications·56 citations·filing 2013–2025
93Inventor score
Top patents by PatentIndex Score
28 records- 0197US10428023B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·22 cites·1 claims
- 0296US10584097B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Mar 10, 2020·14 cites·1 claims
- 0394US11440883B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 13, 2022·3 cites·1 claims
- 0493US11230545B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jan 25, 2022·2 cites·4 claims
- 0589US10577382B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Mar 3, 2020·3 cites·11 claims
- 0688US11987586B1Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonistsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted May 21, 2024·1 cites·16 claims
- 0787US11319286B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 3, 2022·4 cites·10 claims
- 0886US2024360080A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0984US11655241B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted May 23, 2023·2 cites·15 claims
- 1083US2025034141A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1180US12421188B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 23, 2025·0 cites·19 claims
- 1280US12415782B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 16, 2025·0 cites·19 claims
- 1380US12404237B2Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivativesTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 2, 2025·0 cites·19 claims
- 1476US12152027B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Nov 26, 2024·0 cites·4 claims
- 1576US10981934B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 20, 2021·1 cites·5 claims
- 1676US2023063805A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1775US9296746B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Mar 29, 2016·3 cites·13 claims
- 1875US2021276949A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1973US11897879B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Feb 13, 2024·0 cites·9 claims
- 2070US11390634B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 19, 2022·0 cites·10 claims
- 2167US9624184B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Apr 18, 2017·1 cites·10 claims
- 2263US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 2355US12358879B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 15, 2025·0 cites·15 claims
- 2455US2025250230A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2552US12091410B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 17, 2024·0 cites·13 claims
- 2651US12448377B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Oct 21, 2025·0 cites·16 claims
- 2751US12071434B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Aug 27, 2024·0 cites·14 claims
- 2832US2017015654A1Pyridazine compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yoshiteru Ito files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →